Imcivree Approved for Weight Management in Bardet-Biedl Syndrome
Imcivree is a melanocortin 4 receptor (MC4R) agonist that re-establishes MC4 receptor pathway activity to reduce hunger and promote weight loss.
Obesity
Efficacy of GLP-1 Agonists for Weight Loss in Adults Without Diabetes
Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.
Excessive Body Weight Lessens the Efficacy of Vitamin D Supplements
A round up of studies suggests it is difficult to increase serum total 25-hydroxyvitamin D levels enough to effectively lower elevated parathyroid hormone (PTH) levels in overweight patients with chronic kidney disease.
Obesity in Adolescence Linked to Type 1 Diabetes in Adulthood
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Obesity-Associated Microvascular and Macrovascular Complications Among Patients With Diabetes
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
Maintenance of Intermittent Fasting for Weight Loss and Metabolic Health Improvements
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
AHA Outlines Strategies to Improve Nutrition Security in the US
While food insecurity is a leading public health issue, research shows that nutrition security may be a better target for disease prevention strategies.
Integrated Cognitive and Balance Intervention Improves Depression Symptoms
The ENGAGE-2 Mechanistic Pilot trial was a randomized clinical trial conducted at the University of Illinois at Chicago and Stanford University between 2019 and 2020.
Screening Tool Combats Food Insecurity and Pediatric Obesity
The aim of the study was to identify individuals with food insecurity and establish processes to refer patients and families to federal and community resources.
Tirzepatide Superior to Placebo in Weight Loss Study
The SURMOUNT-1 trial evaluated tirzepatide as an adjunct to a reduced-calorie diet and increased physical activity in adults without type 2 diabetes who have obesity or are overweight.
- Loading...
Loading...
Next post in News
Loading... 
Loading...